Symbols

Symbols

AInvest★★★★★3-DAY FREE

Catch pre-market movers with AI signals.

Claim Trial

AKRO(Delisted)

Akero Therapeutics·NASDAQ

--

--(--)

Stock Overview

0.00 / 10Overall Score

—Investment Rating

RiskExcellent

Drawing on fundamental quality of 0.00/10, technical read of 0.00/10, and market sentiment of 0.00/10, AKRO's overall diagnostic stands at 0.00/10 — a — rating.
The five-dimensional fundamental profile of AKRO — Value 0.00, Future 0.00, Past 0.00, Health 0.00, Dividend 0.00 — aggregates to 0.00/10, earning a — rating.
Weighing recent momentum, trend, and candlestick pattern signals, AKRO's technical footprint settles at 0.00/10 — rated —.
The combined read of institutional fund flow activity and sell-side analyst consensus places AKRO's market sentiment at 0.00/10 — a — rating.

Shareholder Returns

AKROIndustryMarket

7 Day------

30 Day------

90 Day------

1 Year------

3 Year------

5 Year------

Include Dividend Returns

Akero Therapeutics Corporation Fundamentals Summary

--P/E Ratio

--P/S Ratio

--P/B Ratio

Market cap--

Earnings--

Revenue--

Trend Analysis of AKRO

Based on a composite score of 3.92/10, we rate AKRO as a Netural. Our analysis breaks down into 2.38/10 for Fundamentals, 3.78/10 for Technicals, and 4.76/10 for Sentiment, indicating the stock is likely to consolidate sideways.

Is AKRO undervalued or overvalued?

Technical Analysis of AKRO

Is money flowing into or out of AKRO?